Great Point Partners LLC Context Therapeutics Inc. Transaction History
Great Point Partners LLC
- $152 Million
- Q4 2024
A detailed history of Great Point Partners LLC transactions in Context Therapeutics Inc. stock. As of the latest transaction made, Great Point Partners LLC holds 4,683,711 shares of CNTX stock, worth $3.79 Million. This represents 3.06% of its overall portfolio holdings.
Number of Shares
4,683,711
Previous 6,934,982
32.46%
Holding current value
$3.79 Million
Previous $13.6 Million
65.89%
% of portfolio
3.06%
Previous 6.28%
Shares
3 transactions
Others Institutions Holding CNTX
# of Institutions
55Shares Held
72.9MCall Options Held
0Put Options Held
0-
Bio Impact Capital LLC Cambridge, MA14.7MShares$11.9 Million2.18% of portfolio
-
Avidity Partners Management LP Dallas, TX7.48MShares$6.06 Million0.84% of portfolio
-
Nextech Invest Ag7.42MShares$6.01 Million1.37% of portfolio
-
Deep Track Capital, LP Greenwich, CT7.42MShares$6.01 Million0.32% of portfolio
-
Blue Owl Capital Holdings LP New York, NY6.36MShares$5.15 Million2.69% of portfolio
About Context Therapeutics Inc.
- Ticker CNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,966,100
- Market Cap $12.9M
- Description
- Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead product candidate is onapristone extended release (ONA-XR), a potent and selective antagonist of the progesterone receptor that is linked to resistance for various classes of cancer therape...